Clinical trials
Completed Uterine Cervical Neoplasms trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
39 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 1 |
| 2009 | 2 |
| 2010 | 4 |
| 2011 | 3 |
| 2012 | 2 |
| 2013 | 1 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 3 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 4 |
| 2023 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 39 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Royal Marsden NHS Foundation Trust | 5 |
| GlaxoSmithKline | 3 |
| Seagen Inc. | 3 |
| AstraZeneca | 2 |
| Barts & The London NHS Trust | 2 |
| European Organisation for Research and Treatment of Cancer - EORTC | 2 |
| Imperial College London | 2 |
| The Christie NHS Foundation Trust | 2 |
| Astellas Pharma Inc | 1 |
| Barts and the London School of Medicine and Dentistry | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Uterine Cervical Neoplasms | 39 |
| Endometrial Neoplasms | 14 |
| Ovarian Neoplasms | 12 |
| Urinary Bladder Neoplasms | 7 |
| Esophageal Neoplasms | 6 |
| Carcinoma, Non-Small-Cell Lung | 5 |
| Papillomavirus Infections | 5 |
| Prostatic Neoplasms | 5 |
| Sarcoma | 5 |
| Vaginal Neoplasms | 5 |
Trials
Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.